Pressao Medical is an early-stage company focused on the development of a smart wearable, non-invasive energy-based system for the treatment of uncontrolled hypertension & prehypertension.
BP-ADJUSTTM will be the first-to-market device of its kind and available over-the-counter. We expect this breakthrough technology will be more effective in combination with drugs to treat uncontrolled hypertension & prehypertension. BP-ADJUSTTM delivers localized energy to the median nerve, which is part of the peripheral nervous system, to signal down-regulation of the sympathetic outflow and reduce BP.
Our board of directors is comprised of a a proven management team with several successful exits in medical device and technology fields. MEET THE TEAM
Pressao Medical was incorporated in Delaware in 2018 and filed multiple patent applications covering broad method and techniques for Class II devices.
Pressao Medical has initial seed funding completed to develop early concepts. We are now accepting first round investments to finance activities leading up to product launch.